Victoria J. Madden

Victoria J. Madden

Auto-generated profile, based on publicly available information

Victoria J. Madden

Microscopy Services Laboratory, University of North Carolina at Chapel Hill, Chapel Hill, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2021 in Nature
Verified
Journal Article
Closed access
PDF file
AWAngela Wahl
Angela Wahl
LGLisa E. Gralinski
Lisa E. Gralinski
CJClaire E. Johnson
Claire E. Johnson
WYWenbo Yao
Wenbo Yao
MKMartina Kovarova
Martina Kovarova
JGJ. Victor Garcia
J. Victor Garcia

7 March 2016 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
JHJenna B. Honeycutt
Jenna B. Honeycutt
AWAngela Wahl
Angela Wahl
CBCaroline Baker
Caroline Baker
RSRae Ann Spagnuolo
Rae Ann Spagnuolo
JFJohn Foster
John Foster
JGJ. Victor Garcia
J. Victor Garcia
Macrophages have long been considered to contribute to HIV infection of the CNS; however, a recent study has contradicted this early work and suggests that myeloid cells are not an in vivo source of virus production. Here, we addressed the role of macrophages in HIV infection by first analyzing monocytes isolated from viremic patients and patients undergoing antiretroviral treatment. We were unable to find viral DNA or viral outgrowth in monocytes isolated from peripheral blood. To determine whether tissue macrophages are productively infected, we used 3 different but complementary humanized mouse models. Two of these models (bone marrow/liver/thymus [BLT] mice and T cell–only mice [ToM]) have been previously described, and the third model was generated by reconstituting immunodeficient mice with human CD34+ hematopoietic stem cells that were devoid of human T cells (myeloid-only mice [MoM]) to specifically evaluate HIV replication in this population. Using MoM, we demonstrated that macrophages can sustain HIV replication in the absence of T cells; HIV-infected macrophages are distributed in various tissues including the brain; replication-competent virus can be rescued ex vivo from infected macrophages; and infected macrophages can establish de novo infection. Together, these results demonstrate that macrophages represent a genuine target for HIV infection in vivo that can sustain and transmit infection.

27 July 2014 in Nature Medicine
Verified
Journal Article
Open access
PDF file
DYDaisuke Yamane
Daisuke Yamane
DMDavid R. McGivern
David R. McGivern
EWEliane Wauthier
Eliane Wauthier
MYMinKyung Yi
MinKyung Yi
VMVictoria J Madden
Victoria J Madden
SLStanley Lemon
Stanley Lemon
Stanley Lemon and colleagues show that the HCV replicase is sensitive to lipid peroxidation, which may restrict viral replication in vitro and in vivo. Oxidative tissue injury often accompanies viral infection, yet there is little understanding of how it influences virus replication. We show that multiple hepatitis C virus (HCV) genotypes are exquisitely sensitive to oxidative membrane damage, a property distinguishing them from other pathogenic RNA viruses. Lipid peroxidation, regulated in part through sphingosine kinase-2, severely restricts HCV replication in Huh-7 cells and primary human hepatoblasts. Endogenous oxidative membrane damage lowers the 50% effective concentration of direct-acting antivirals in vitro, suggesting critical regulation of the conformation of the NS3-4A protease and the NS5B polymerase, membrane-bound HCV replicase components. Resistance to lipid peroxidation maps genetically to transmembrane and membrane-proximal residues within these proteins and is essential for robust replication in cell culture, as exemplified by the atypical JFH1 strain of HCV. Thus, the typical, wild-type HCV replicase is uniquely regulated by lipid peroxidation, providing a mechanism for attenuating replication in stressed tissue and possibly facilitating long-term viral persistence.

4 November 2019 in eLife
Verified
Journal Article
Open access
RBRachel A Battaglia
Rachel A Battaglia
ABAdriana S Beltran
Adriana S Beltran
SDSamed Delic
Samed Delic
RDRaluca Dumitru
Raluca Dumitru
JRJasmine A Robinson
Jasmine A Robinson
NSNatasha T Snider
Natasha T Snider
Alexander disease (AxD) is a fatal neurodegenerative disorder caused by mutations in glial fibrillary acidic protein (GFAP), which supports the structural integrity of astrocytes. Over 70 GFAP missense mutations cause AxD, but the mechanism linking different mutations to disease-relevant phenotypes remains unknown. We used AxD patient brain tissue and induced pluripotent stem cell (iPSC)-derived astrocytes to investigate the hypothesis that AxD-causing mutations perturb key post-translational modifications (PTMs) on GFAP. Our findings reveal selective phosphorylation of GFAP-Ser13 in patients who died young, independently of the mutation they carried. AxD iPSC-astrocytes accumulated pSer13-GFAP in cytoplasmic aggregates within deep nuclear invaginations, resembling the hallmark Rosenthal fibers observed in vivo. Ser13 phosphorylation facilitated GFAP aggregation and was associated with increased GFAP proteolysis by caspase-6. Furthermore, caspase-6 was selectively expressed in young AxD patients, and correlated with the presence of cleaved GFAP. We reveal a novel PTM signature linking different GFAP mutations in infantile AxD.

1 October 2020 in Journal of Biological Chemistry
Verified
Journal Article
Open access
NRNambirajan Rangarajan
Nambirajan Rangarajan
IKIshani Kapoor
Ishani Kapoor
SLShuang Li
Shuang Li
PDPeter Drossopoulos
Peter Drossopoulos
KWKristen K. White
Kristen K. White
HDHenrik G. Dohlman
Henrik G. Dohlman
Autophagy is a conserved process that recycles cellular contents to promote survival. Although nitrogen limitation is the canonical inducer of autophagy, recent studies have revealed several other nutrients important to this process. In this study, we used a quantitative, high-throughput assay to identify potassium starvation as a new and potent inducer of autophagy in the yeast Saccharomyces cerevisiae. We found that potassium-dependent autophagy requires the core pathway kinases Atg1, Atg5, and Vps34, and other components of the phosphatidylinositol 3-kinase complex. Transmission EM revealed abundant autophagosome formation in response to both stimuli. RNA-Seq indicated distinct transcriptional responses: nitrogen affects transport of ions such as copper, whereas potassium targets the organization of other cellular components. Thus, nitrogen and potassium share the ability to influence molecular supply and demand but do so in different ways. Both inputs promote catabolism through bulk autophagy, but result in distinct mechanisms of cellular remodeling and synthesis.

24 September 2020 in Research Square
Verified
Preprint
Open access
PDF file
AWAngela Wahl
Angela Wahl
LGLisa Gralinski
Lisa Gralinski
CJClaire Johnson
Claire Johnson
WYWenbo Yao
Wenbo Yao
MKMartina Kovarova
Martina Kovarova
JGJ. Victor Garcia
J. Victor Garcia
All known recently emerged human coronaviruses likely originated in bats. Here, we used a single experimental platform based on human lung-only mice (LoM) to demonstrate efficient in vivo replication of all recently emerged human coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2) and two highly relevant endogenous pre-pandemic SARS-like bat coronaviruses. Virus replication in this model occurs in bona fide human lung tissue and does not require any type of adaptation of the virus or the host. Our results indicate that bats harbor endogenous coronaviruses capable of direct transmission into humans. Further detailed analysis of pandemic SARS-CoV-2 in vivo infection of LoM human lung tissue showed predominant infection of human lung epithelial cells, including type II pneumocytes present in alveoli and ciliated airway cells. Acute SARS-CoV-2 infection was highly cytopathic and induced a robust and sustained Type I interferon and inflammatory cytokine/chemokine response. Finally, we evaluated a pre-exposure prophylaxis strategy for coronavirus infection. Our results show that prophylactic administration of EIDD-2801, an oral broad spectrum antiviral currently in phase II clinical trials for the treatment of COVID-19, dramatically prevented SARS-CoV-2 infection in vivo and thus has significant potential for the prevention and treatment of COVID-19.